Navigation Links
UK Scientists to Undertake Seven Year Study of Peanut Allergy

Peanut allergy is increasingly common, affecting one in 70 schoolchildren, available data says. The question is whether early exposure can prevent the allergy.

A joint team of scientists from the King's College London and doctors at Guy's and St Thomas' hospital, are taking up a seven-year study and hope to rope in 480 children in the seven-year study.

The babies being studied are between four and 11 months and already have eczema or egg allergy, putting them at high risk of being allergic to peanuts.

Current guidelines advise women to avoid nuts during pregnancy if there is a family history of allergy. This group is also advised not to give their babies peanuts before they are three-years-old.

It is not clear how to prevent peanut allergy. Some studies suggest that peanut avoidance in early infancy may help to prevent allergy, whereas other research suggests the opposite may be true.

Professor Gideon Lack, who will be leading the Leap (Learning Early About Peanut allergies) study, has been looking into the subject for many years.

He said: "Recent evidence suggests that children who eat peanut snacks early in life may in fact be protected against peanut allergy, in contrast with previous studies which have suggested the opposite."

In the study, the babies will be divided into two groups. One will receive a peanut snack regularly for the first three years of life, whereas the control group will completely avoid peanuts.

Both groups will be assessed for peanut allergy when they are five-years-old.

Professor Lack said, "Determining whether avoidance or early exposure to peanut prevents the development of peanut allergy and understanding how this happens will have important clinical implications.

"Our study findings may result in a change in public health policy to prevent food allergies and will enable scientists to identify important treatment targets to try
'"/>




Page: 1 2

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
(Date:7/25/2008)...ewswire-FirstCall/ -- Thoratec,Corporation (Nasdaq...l,circulatory support therapies to save, support a... will report its operating results for the second,...rsday, July 31., The company will hold a conferen...ting activities to all interested parties at 1:30 ...
(Date:7/25/2008)...nsumers tips and encourages them to, ,Speak Up,(T...July 25 /PRNewswire-USNewswire/ -- The Pennsylvani...l Patient Safety Day" which,is a national effort t...pate fully in their healthcare by asking questions...ery or illness., "We understand the important rol...
(Date:7/25/2008)...ing Exclusivity Begins -, CORONA, Calif., July 25... Inc. (NYSE: WPI ), a leading specialty pharmaceu... has commenced commercial,shipment of its Omeprazo...g,strength from its Davie, Florida manufacturing f...s 180 days of marketing exclusivity for being the,...
(Date:7/25/2008)...iance to be presented at Fenway Park ... 25 /PRNewswire/ -- CVS/pharmacy announced today,t... million in just 21 days,through its annual in-sto...the seventh year of the annual fundraising effort ...or ALS research. This year,s fundraiser took,place...
Breaking Medicine News(10 mins):Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2
...ve been killed in Turkey with the object of combat...untry. This has been revealed by the Turkish Natio...ion has been detected in as many as 13 provinces i...uspected cases. The provinces where the bird flu h...
...eing sued by four Marlboro smokers for hi-tech scr...r. The four people are demanding that the company .... //If this were to be brought into force, it will... of early detection. The company has been accused ...
... prove to be as beneficial to people suffering fro...is has been revealed by a Dutch study. The same am...tients who underwent these two therapies, when com...t at all. A combination of both the treatments did...
...nce a day for treating AIDS is sought to be develo...Gilead Sciences Inc. The regimen of three drugs wi... receive a formal approval towards end 2006. //As ...fected by AIDS, with the poor nations accounting f...
Other Medicine News:
(Date:7/24/2008)..., July 24 /- Alexza,Pharmac...at it has initiated,its second Phase 3 clinical tr...an inhalation product candidate being developed fo...h schizophrenia or bipolar disorder.,Alexza believ...cokinetic,(PK) properties resulting from inhaled l...
(Date:7/24/2008)...PRNewswire-USNewswire/ -- Headlines claiming "soy,...story. The small scale,preliminary study that Dr....ction, is based on recollected intake of soyfoods ...is study is confounded by many,issues, thus I feel...,caution," warned Dr. Tammy Hedlund, a researcher ...
(Date:7/24/2008)...eter designed to take body temperature, for home,a...e-FirstCall/ --- Kidz-Med, Inc.,(subsidiary of Ame...,United States distributor of the Thermofocus(R) ...unce the results of a clinical study,conducted by ...Milan, in,Milan, Italy, which proves that the Ther...
(Date:7/24/2008)...nce, July 24 /- NicOx S.A.,... results from the 52-week,open label safety extens...,the 301 phase 3 study for naproxcinod. The result...acy was maintained for the one-year duration of,th...sment scale. In,addition, the results showed that ...
Breaking Medicine Technology:Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6Soyfoods Do Not Impact Sperm Count 2Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4Edge Health Solutions Releases edgeDMS 28TM 29 2 0 and edgeMD 2 0 28TM 29 Revolutionary All in One Practice Management Software with FDA Approved Adv 21239 1Edge Health Solutions Releases edgeDMS 28TM 29 2 0 and edgeMD 2 0 28TM 29 Revolutionary All in One Practice Management Software with FDA Approved Adv 21239 2Lutheran Episcopal Church Presiding Bishops Urge Prayers for Peace in Sudan 21236 1Lutheran Episcopal Church Presiding Bishops Urge Prayers for Peace in Sudan 21236 2AHIMA Reacts in Support of NAHITs New Strategic and Operating Framework 5850 1Sucking Out Clot Debris Helps Heart Attack Patients 21233 1Sucking Out Clot Debris Helps Heart Attack Patients 21233 2Sucking Out Clot Debris Helps Heart Attack Patients 21233 3
... Diamyd Medical AB (<a target="_blank" href=,"http...AM B;, www.otcqx.com ,ticker DMYDY) , , STOCKHOL...on,made in Linkoping, Sweden at the Sweden-Seattle... Johnny Ludvigsson, the Principal,Investigator in ...e,II study in type 1 diabetes, presented potential...
...DURHAM, N.C.--(BUSINESS WIRE)--May 4, 2007 - Argos...data on the immunosuppressive,properties of solubl...g to be held in San Francisco, May 5-9. The presen...sts at the University of,Western Ontario., "These ...raft,survival in transplantation, and that it can ...
Other Medicine Technology:Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 2Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 3Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 4Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 5Argos Therapeutics Presents Immunosuppression Data for Soluble CD83,at the American Society of Transplantation Congress 2007 2
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: